These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1784579)

  • 21. Influence of ointment bases on the in vitro release of methyl salicylate.
    Plakogiannis FM; Yaakob M
    Pharm Acta Helv; 1977; 52(10):236-8. PubMed ID: 611510
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro skin penetration of griseofulvin in rat and human skin from an ointment dosage form.
    Ritschel WA; Hussain AS
    Arzneimittelforschung; 1988 Nov; 38(11):1630-2. PubMed ID: 3214448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.
    Cross SE; Anderson C; Roberts MS
    Br J Clin Pharmacol; 1998 Jul; 46(1):29-35. PubMed ID: 9690946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermal copper drugs: the copper bracelet and cu(II) salicylate complexes.
    Walker WR; Beveridge SJ; Whitehouse MW
    Agents Actions Suppl; 1981; 8():359-67. PubMed ID: 7008557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro release and antiinflammatory activity of topical formulations of ketoprofen.
    Moretti MD; Gavini E; Peana AT
    Boll Chim Farm; 2000; 139(2):67-72. PubMed ID: 10920531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of formulation on the in vitro transdermal penetration of flutrimazole.
    Ramis J; Conte L; Segado X; Forn J; Lauroba J; Calpena A; Escribano E; Domenech J
    Arzneimittelforschung; 1997 Oct; 47(10):1139-44. PubMed ID: 9368709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release study of diclofenac from new carbomer gels.
    Bregni C; Chiappetta D; Faiden N; Carlucci A; García R; Pasquali R
    Pak J Pharm Sci; 2008 Jan; 21(1):12-6. PubMed ID: 18166512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro study of physostigmine salicylate and pilocarpine hydrochloride release from different gel formulations.
    Habib FS; Attia MA; el-Shanawany SM
    Pharmazie; 1986 Feb; 41(2):124-5. PubMed ID: 3725852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of viscosity on drug release from ointments, creams, gels and emulsions].
    Erös I; Soósné-Csányi E; Selmeczi B
    Acta Pharm Hung; 1994 Mar; 64(2):57-61. PubMed ID: 8017209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INFRARED ABSORPTION RATIO METHOD FOR DETERMINATION OF TRIETHANOLAMINE SALICYLATE IN OINTMENT.
    HEISEY HO
    J Pharm Sci; 1964 Dec; 53():1553-4. PubMed ID: 14255150
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of silicone emulsifiers on in vitro skin permeation of sunscreens from cosmetic emulsions.
    Montenegro L; Paolino D; Puglisi G
    J Cosmet Sci; 2004; 55(6):509-18. PubMed ID: 15645107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug release from ointment bases: characteristics, measurement, and evaluation. II. Dialysis cell method.
    Howze JM; Billups NF
    Am J Pharm Sci Support Public Health; 1966; 138(5):193-203. PubMed ID: 5976322
    [No Abstract]   [Full Text] [Related]  

  • 37. Dilution of semi-solid creams: influence of various production parameters on rheological properties and skin penetration.
    Nagelreiter C; Kratochvilova E; Valenta C
    Int J Pharm; 2015 Jan; 478(2):429-38. PubMed ID: 25475015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro sodium salicylate release from a sucrose polyester matrix.
    Castellano PM; Pastoriza MA; Martińez de Bertorello M; Bertorello HE; Horas JA
    J Pharm Sci; 1989 Jul; 78(7):561-2. PubMed ID: 2778655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential dangers from topical preparations containing methyl salicylate.
    Chan TY
    Hum Exp Toxicol; 1996 Sep; 15(9):747-50. PubMed ID: 8880210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamics of drug release from ointment bases. 1. The effect of dimethylsulfoxide on the release of salicylic acid].
    Lakowska J; Botev B; Trandafilov T
    Pharmazie; 1973 Apr; 28(4):252-3. PubMed ID: 4716611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.